Fuda Cancer Hospital, Guangzhou: all 116 studies
Page 2 of 2. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of Mix Vaccine in Hepatocyte Carcinoma PatientCompletedNCT02338778Phase 1/2
- Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma PatientCompletedNCT02338752Phase 1/2
- Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma PatientCompletedNCT02338700Phase 1/2
- Irreversible Electroporation(IRE) For Unresectable Renal TumorsCompletedNCT02335827Not applicable
- Irreversible Electroporation(IRE) For Unresectable Head and Neck NeoplasmsCompletedNCT02335112Not applicable
- Irreversible Electroporation(IRE) For Unresectable Portal Venous Tumor EmboliCompletedNCT02333773Not applicable
- Safety and Efficacy of Mix Vaccine in Lung Carcinoma PatientCompletedNCT02333474Phase 1/2
- Percutaneous Irreversible Electroporation to Treat Liver Cancer Close to the GallbladderCompletedNCT02332551Not applicable
- Percutaneous Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic DomeCompletedNCT02329106Not applicable
- Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells VaccineCompletedNCT02178670Phase 1/2
- A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal CancerCompletedNCT02176746Phase 1/2
- The Immunotherapy of Nasopharyngeal Cancer Using Cancer Stem Cells VaccineCompletedNCT02115958Phase 1/2
- Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer PatientsCompletedNCT02089919Phase 1/2
- Vaccine Therapy in Treating Lung Cancer Patients With Cancer Stem CellsCompletedNCT02084823Phase 1/2
- Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic CancerCompletedNCT02074046Phase 1/2
- Safety Study of Cancer Stem Cell Vaccinie to Treat Breast CancerCompletedNCT02063893